

Ingevity's Evotherm P35 earns German approval after rigorous testing, clearing it for use in warm-mix asphalt for federal projects.

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany's Federal Highway Research Institute, known as BASt.

NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pricing actions drive earnings and boost outlook.

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity announced Dave Li, president and CEO, will speak at the 2026 Wells Fargo Industrials & Materials Conference on Thursday, June 11.

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock?

Ingevity NYSE: NGVT reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance Materials business and continued share repurchases.

Ingevity beats Q1 estimates as pricing actions and FX gains lift sales and earnings, despite weakness in Road Markings and lower asset utilization.

Ingevity Corporation (NGVT) Q1 2026 Earnings Call Transcript
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for NGVT and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.